{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:31:11Z","timestamp":1786735871780,"version":"build-2736575974"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1673-5374.266905","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T08:47:00Z","timestamp":1571388420000},"page":"606","source":"Crossref","is-referenced-by-count":80,"title":["MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression"],"prefix":"10.4103","volume":"15","author":[{"given":"PhilipV","family":"Peplow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.266905-1","doi-asserted-by":"crossref","unstructured":"Ahlbrecht J, Martino F, Pul R, Skripuletz T, S\u00fchs KW, Schauerte C, Yildiz \u00d6, Trebst C, Tasto L, Thum S, Pfanne A, Roesler R, Lauda F, Hecker M, Zettl UK, Tumani H, Thum T, Stangel M (2016) Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis. Mult Scler 22:1202-1214.","DOI":"10.1177\/1352458515613641"},{"key":"key-10.4103\/1673-5374.266905-2","doi-asserted-by":"crossref","unstructured":"Alroughani R, Boyko A (2018) Pediatric multiple sclerosis: a review. BMC Neurol 18:27.","DOI":"10.1186\/s12883-018-1026-3"},{"key":"key-10.4103\/1673-5374.266905-3","doi-asserted-by":"crossref","unstructured":"Angerstein C, Hecker M, Paap BK, Koczan D, Thamilarasan M, Thiesen HJ, Zettl UK (2012) Integration of microRNA databases to study microRNAs associated with multiple sclerosis. Mol Neurobiol 45:520-535.","DOI":"10.1007\/s12035-012-8270-0"},{"key":"key-10.4103\/1673-5374.266905-4","doi-asserted-by":"crossref","unstructured":"Asirvatham AJ, Gregorie CJ, Hu Z, Magner WJ, Tomasi TB (2008) MicroRNA targets in immune genes and the Dicer\/Argonaute and ARE machinery components. Mol Immunol 45:1995-2006.","DOI":"10.1016\/j.molimm.2007.10.035"},{"key":"key-10.4103\/1673-5374.266905-5","doi-asserted-by":"crossref","unstructured":"Aung LL, Balashov KE (2015) Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis. Mult Scler 21:1131-1138.","DOI":"10.1177\/1352458514560923"},{"key":"key-10.4103\/1673-5374.266905-6","doi-asserted-by":"crossref","unstructured":"Backes C, Meese E, Keller A (2016) Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol Diagn Ther 20:509-518.","DOI":"10.1007\/s40291-016-0221-4"},{"key":"key-10.4103\/1673-5374.266905-7","unstructured":"Bayer US (2018) Multiple Sclerosis MS. https:\/\/www.multiplesclerosis.com\/us\/treatment.php; accessed 1 March 2019."},{"key":"key-10.4103\/1673-5374.266905-8","doi-asserted-by":"crossref","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I (2015) Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 14:263-273.","DOI":"10.1016\/S1474-4422(14)70267-4"},{"key":"key-10.4103\/1673-5374.266905-9","doi-asserted-by":"crossref","unstructured":"Benson LA, Healy BC, Gorman MP, Baruch NF, Gholipour T, Musallam A, Chitnis T (2014) Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Mult Scler Relat Dis 3:186-193.","DOI":"10.1016\/j.msard.2013.06.004"},{"key":"key-10.4103\/1673-5374.266905-10","doi-asserted-by":"crossref","unstructured":"Bergman P, Piket E, Khademi M, James T, Brundin L, Olsson T, Piehl F, Jagodic M (2016) Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e219.","DOI":"10.1212\/NXI.0000000000000219"},{"key":"key-10.4103\/1673-5374.266905-11","doi-asserted-by":"crossref","unstructured":"Bernhardt K, Haar J, Tsai MH, Poirey R, Feederle R, Delecluse HJ (2016) A viral microRNA cluster regulates the expression of PTEN, p27 and of a bcl-2 homolog. PLoS Pathog 12:e1005405.","DOI":"10.1371\/journal.ppat.1005405"},{"key":"key-10.4103\/1673-5374.266905-12","doi-asserted-by":"crossref","unstructured":"Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D (2002) Early onset multiple sclerosis: a longitudinal study. Neurology 59:1006-1010.","DOI":"10.1212\/WNL.59.7.1006"},{"key":"key-10.4103\/1673-5374.266905-13","doi-asserted-by":"crossref","unstructured":"Catalanotto C, Cogoni C, Zardo G (2016) MicroRNA in control of gene expression: An overview of nuclear functions. Int J Mol Sci 17:1712.","DOI":"10.3390\/ijms17101712"},{"key":"key-10.4103\/1673-5374.266905-14","unstructured":"de Faria O Jr, Moore CS, Kennedy TE, Antel JP, Bar-Or A, Dhaunchak AS (2012) MicroRNA dysregulation in multiple sclerosis. Front Genet 3: 311."},{"key":"key-10.4103\/1673-5374.266905-15","doi-asserted-by":"crossref","unstructured":"Divekar AA, Dubey S, Gangalum PR, Singh RR (2011) Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol 186:924-930.","DOI":"10.4049\/jimmunol.1002218"},{"key":"key-10.4103\/1673-5374.266905-16","doi-asserted-by":"crossref","unstructured":"Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z, Pei G (2009) MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10:1252-1259.","DOI":"10.1038\/ni.1798"},{"key":"key-10.4103\/1673-5374.266905-17","doi-asserted-by":"crossref","unstructured":"Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA (2010) Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597-611.","DOI":"10.1016\/j.neuron.2010.01.027"},{"key":"key-10.4103\/1673-5374.266905-18","doi-asserted-by":"crossref","unstructured":"Dulamea AO (2017) The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies. Neural Regen Res 12:1939-1944.","DOI":"10.4103\/1673-5374.221146"},{"key":"key-10.4103\/1673-5374.266905-19","doi-asserted-by":"crossref","unstructured":"Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, Beadnall H, Barnett MH, Suter CM, Buckland ME (2017) Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep 7:14293.","DOI":"10.1038\/s41598-017-14301-3"},{"key":"key-10.4103\/1673-5374.266905-20","doi-asserted-by":"crossref","unstructured":"Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861-874.","DOI":"10.1038\/nrg3074"},{"key":"key-10.4103\/1673-5374.266905-21","doi-asserted-by":"crossref","unstructured":"Fawaz CN, Makki IS, Kazan JM, Gebara NY, Andary FS, Itani MM, El-Sayyed M, Zeidan A, Quartarone A, Darwish H, Mondello S (2015) Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research. Expert Rev Proteomics 12:637-650.","DOI":"10.1586\/14789450.2015.1099435"},{"key":"key-10.4103\/1673-5374.266905-22","doi-asserted-by":"crossref","unstructured":"Fayyad-Kazan H, Hamade E, Rouas R, Najar M, Fayyad-Kazan M, El Zein N, ElDirani R, Hussein N, Fakhry M, Al-Akoum C, Burny A, Martiat P, Badran B (2014) Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-\u03b3 secreted by activated human CD4 lymphocytes. Hum Immunol 75:677-685.","DOI":"10.1016\/j.humimm.2014.01.007"},{"key":"key-10.4103\/1673-5374.266905-23","doi-asserted-by":"crossref","unstructured":"Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, Villa C, Pietroboni AM, Naismith RT, Alvarez E, Parks BJ, Bresolin N, Cross AH, Piccio LM, Galimberti D, Scarpini E (2013) Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult Scler 19:1938-1942.","DOI":"10.1177\/1352458513485654"},{"key":"key-10.4103\/1673-5374.266905-24","doi-asserted-by":"crossref","unstructured":"Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7:e30679.","DOI":"10.1371\/journal.pone.0030679"},{"key":"key-10.4103\/1673-5374.266905-25","doi-asserted-by":"crossref","unstructured":"Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73:729-740.","DOI":"10.1002\/ana.23880"},{"key":"key-10.4103\/1673-5374.266905-26","doi-asserted-by":"crossref","unstructured":"Gascon E, Gao FB (2012) Cause or effect: misregulation of microRNA pathways in neurodegeneration. Front Neurosci 6:48.","DOI":"10.3389\/fnins.2012.00048"},{"key":"key-10.4103\/1673-5374.266905-27","doi-asserted-by":"crossref","unstructured":"Geurts JJ, Calabrese M, Fisher E, Rudick RA (2012) Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol 11:1082-1092.","DOI":"10.1016\/S1474-4422(12)70230-2"},{"key":"key-10.4103\/1673-5374.266905-28","doi-asserted-by":"crossref","unstructured":"Gewies A, Gorka O, Bergmann H, Pechloff K, Petermann F, Jeltsch KM, Rudelius M, Kriegsmann M, Weichert W, Horsch M, Beckers J, Wurst W, Heikenwalder M, Korn T, Heissmeyer V, Ruland J (2014) Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. Cell Rep 9:1292-1305.","DOI":"10.1016\/j.celrep.2014.10.044"},{"key":"key-10.4103\/1673-5374.266905-29","doi-asserted-by":"crossref","unstructured":"Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, D\u00e9card BF, Thum T, Gold R (2012) Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology 79:2166-2170.","DOI":"10.1212\/WNL.0b013e3182759621"},{"key":"key-10.4103\/1673-5374.266905-30","doi-asserted-by":"crossref","unstructured":"Harris VK, Tuddenham JF, Sadiq SA (2017) Biomarkers of multiple sclerosis: current findings. Degener Neurol Neuromuscul Dis 7:19-29.","DOI":"10.2147\/DNND.S98936"},{"key":"key-10.4103\/1673-5374.266905-31","doi-asserted-by":"crossref","unstructured":"Hecker M, Thamilarasan M, Koczan D, Schr\u00f6der I, Flechtner K, Freiesleben S, F\u00fcllen G, Thiesen HJ, Zettl UK (2013) MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. Int J Mol Sci 14:16087-16110.","DOI":"10.3390\/ijms140816087"},{"key":"key-10.4103\/1673-5374.266905-32","doi-asserted-by":"crossref","unstructured":"Housley WJ, Pitt D, Hafler DA (2015) Biomarkers in multiple sclerosis. Clin Immunol 161:51-58.","DOI":"10.1016\/j.clim.2015.06.015"},{"key":"key-10.4103\/1673-5374.266905-33","doi-asserted-by":"crossref","unstructured":"Huang Q, Xiao B, Ma X, Qu M, Li Y, Nagarkatti P, Nagarkatti M, Zhou J (2016) MicroRNAs associated with the pathogenesis of multiple sclerosis. J Neuroimmunol 295-296:148-161.","DOI":"10.1016\/j.jneuroim.2016.04.014"},{"key":"key-10.4103\/1673-5374.266905-34","doi-asserted-by":"crossref","unstructured":"Jafari N, Shaghaghi H, Mahmoodi D, Shirzad Z, Alibeiki F, Bohlooli S, Dogaheh HP (2015) Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients. J Clin Neurosci 22:200-203.","DOI":"10.1016\/j.jocn.2014.06.106"},{"key":"key-10.4103\/1673-5374.266905-35","doi-asserted-by":"crossref","unstructured":"Jaworski M, Marsland BJ, Gehrig J, Held W, Favre S, Luther SA, Perroud M, Golshayan D, Gaide O, Thome M (2014) Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity. EMBO J 33:2765-2781.","DOI":"10.15252\/embj.201488987"},{"key":"key-10.4103\/1673-5374.266905-36","doi-asserted-by":"crossref","unstructured":"Jern\u00e5s M, Malmestr\u00f6m C, Axelsson M, Nookaew I, Wadenvik H, Lycke J, Olsson B (2013) MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol 14:32.","DOI":"10.1186\/1471-2172-14-32"},{"key":"key-10.4103\/1673-5374.266905-37","doi-asserted-by":"crossref","unstructured":"Junker A (2011) Pathophysiology of translational regulation by microRNAs in multiple sclerosis. FEBS Lett 585:3738-3746.","DOI":"10.1016\/j.febslet.2011.03.052"},{"key":"key-10.4103\/1673-5374.266905-38","doi-asserted-by":"crossref","unstructured":"Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132:3342-3352.","DOI":"10.1093\/brain\/awp300"},{"key":"key-10.4103\/1673-5374.266905-39","doi-asserted-by":"crossref","unstructured":"Kacperska MJ, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A (2015) Selected extracellular microRNAs as potential biomarkers of multiple sclerosis activity -preliminary study. J Mol Neurosci 56:154-163.","DOI":"10.1007\/s12031-014-0476-3"},{"key":"key-10.4103\/1673-5374.266905-40","doi-asserted-by":"crossref","unstructured":"Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Bauer L, Jakobs P, Pohl C, Sandbrink R (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67:1242-1249.","DOI":"10.1212\/01.wnl.0000237641.33768.8d"},{"key":"key-10.4103\/1673-5374.266905-41","doi-asserted-by":"crossref","unstructured":"Katz Sand I (2015) Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol 28:193-205.","DOI":"10.1097\/WCO.0000000000000206"},{"key":"key-10.4103\/1673-5374.266905-42","doi-asserted-by":"crossref","unstructured":"Kemppinen AK, Kaprio J, Palotie A, Saarela J (2011) Systematic review of genome-wide expression studies in multiple sclerosis. BMJ Open 1:e000053.","DOI":"10.1136\/bmjopen-2011-000053"},{"key":"key-10.4103\/1673-5374.266905-43","doi-asserted-by":"crossref","unstructured":"Koning N, B\u00f6 L, Hoek RM, Huitinga I (2007) Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62:504-514.","DOI":"10.1002\/ana.21220"},{"key":"key-10.4103\/1673-5374.266905-44","doi-asserted-by":"crossref","unstructured":"K\u00fc\u00e7\u00fckali C\u0130, K\u00fcrt\u00fcnc\u00fc M, \u00c7oban A, \u00c7ebi M, T\u00fcz\u00fcn E (2015) Epigenetics of multiple sclerosis: an updated review. Neuromolecular Med 17: 83-96.","DOI":"10.1007\/s12017-014-8298-6"},{"key":"key-10.4103\/1673-5374.266905-45","doi-asserted-by":"crossref","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452.","DOI":"10.1212\/WNL.33.11.1444"},{"key":"key-10.4103\/1673-5374.266905-46","doi-asserted-by":"crossref","unstructured":"Kurtzke JF (2015) On the origin of EDSS. Mult Scler Relat Disord 4:95-103.","DOI":"10.1016\/j.msard.2015.02.003"},{"key":"key-10.4103\/1673-5374.266905-47","doi-asserted-by":"crossref","unstructured":"Kutzelnigg A, Lassmann H (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 122:15-58.","DOI":"10.1016\/B978-0-444-52001-2.00002-9"},{"key":"key-10.4103\/1673-5374.266905-48","doi-asserted-by":"crossref","unstructured":"Lee JY, Park JK, Lee EY, Lee EB, Song YW (2016) Circulating exosomes from patients with systemic lupus erythematosus induce a proinflammatory immune response. Arthritis Res Ther 18:264.","DOI":"10.1186\/s13075-016-1159-y"},{"key":"key-10.4103\/1673-5374.266905-49","doi-asserted-by":"crossref","unstructured":"Liguori M, Nuzziello N, Licciulli F, Consiglio A, Simone M, Viterbo RG, Creanza TM, Ancona N, Tortorella C, Margari L, Grillo G, Giordano P, Liuni S, Trojano M (2018) Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. Hum Mol Genet 27:66-79.","DOI":"10.1093\/hmg\/ddx385"},{"key":"key-10.4103\/1673-5374.266905-50","doi-asserted-by":"crossref","unstructured":"Long H, Wang X, Chen Y, Wang L, Zhao M, Lu Q (2018) Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets. Cancer Lett 428:90-103.","DOI":"10.1016\/j.canlet.2018.04.016"},{"key":"key-10.4103\/1673-5374.266905-51","doi-asserted-by":"crossref","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911.","DOI":"10.1212\/WNL.46.4.907"},{"key":"key-10.4103\/1673-5374.266905-52","doi-asserted-by":"crossref","unstructured":"Lykken EA, Li QJ (2016) The microRNA miR-191 supports T cell survival following common \u03b3 chain signaling. J Biol Chem 291:23532-23544.","DOI":"10.1074\/jbc.M116.741264"},{"key":"key-10.4103\/1673-5374.266905-53","doi-asserted-by":"crossref","unstructured":"Lytle JR, Yario TA, Steitz JA (2007) Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5\u2019 UTR as in the 3\u2019 UTR. Proc Natl Acad Sci U S A 104:9667-9672.","DOI":"10.1073\/pnas.0703820104"},{"key":"key-10.4103\/1673-5374.266905-54","doi-asserted-by":"crossref","unstructured":"Magner WJ, Weinstock-Guttman B, Rho M, Hojnacki D, Ghazi R, Ramanathan M, Tomasi TB (2016) Dicer and microRNA expression in multiple sclerosis and response to interferon therapy. J Neuroimmunol 292:68-78.","DOI":"10.1016\/j.jneuroim.2016.01.009"},{"key":"key-10.4103\/1673-5374.266905-55","doi-asserted-by":"crossref","unstructured":"Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, Parenti AR, Daidone MG, Bicciato S, Piccolo S (2010) A MicroRNA targeting dicer for metastasis control. Cell 141:1195-1207.","DOI":"10.1016\/j.cell.2010.05.017"},{"key":"key-10.4103\/1673-5374.266905-56","doi-asserted-by":"crossref","unstructured":"Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G (2015) Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. J Transl Med 13:261.","DOI":"10.1186\/s12967-015-0623-9"},{"key":"key-10.4103\/1673-5374.266905-57","doi-asserted-by":"crossref","unstructured":"Moutinho C, Esteller M (2017) MicroRNAs and epigenetics. Adv Cancer Res 135:189-220.","DOI":"10.1016\/bs.acr.2017.06.003"},{"key":"key-10.4103\/1673-5374.266905-58","unstructured":"Multiple Sclerosis Trust (2018) Prevalence and incidence of multiple sclerosis. https:\/\/www.mstrust.org.uk\/a-z\/prevalence-and-incidence-multiple-sclerosis; accessed 1 March 2019."},{"key":"key-10.4103\/1673-5374.266905-59","unstructured":"National MS Society, Just the facts. https:\/\/www.nationalmssociety.org\/nationalmssociety\/media\/msnationalfiles\/brochures\/brochure-just-the-facts.pdf; accessed 1 March 2019."},{"key":"key-10.4103\/1673-5374.266905-60","unstructured":"National MS Society, Who gets MS? (Epidemiology) https:\/\/www.nationalmssociety.org\/What-is-MS\/Who-Gets-MS; accessed 1 March 2019."},{"key":"key-10.4103\/1673-5374.266905-61","doi-asserted-by":"crossref","unstructured":"Niwald M, Migdalska-S\u0119k M, Brzezia\u0144ska-Lasota E, Miller E (2017) Evaluation of selected microRNAs expression in remission phase of multiple sclerosis and their potential link to cognition, depression, and disability. J Mol Neurosci 63:275-282.","DOI":"10.1007\/s12031-017-0977-y"},{"key":"key-10.4103\/1673-5374.266905-62","doi-asserted-by":"crossref","unstructured":"Nuzziello N, Vilardo L, Pelucchi P, Consiglio A, Liuni S, Trojano M, Liguori M (2018) Investigating the role of microRNA and transcription factor co-regulatory networks in multiple sclerosis pathogenesis. Int J Mol Sci 19:3652.","DOI":"10.3390\/ijms19113652"},{"key":"key-10.4103\/1673-5374.266905-63","doi-asserted-by":"crossref","unstructured":"O\u2019Connell RM, Rao DS, Baltimore D (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30:295-312.","DOI":"10.1146\/annurev-immunol-020711-075013"},{"key":"key-10.4103\/1673-5374.266905-64","doi-asserted-by":"crossref","unstructured":"Oksenberg JR, Baranzini SE (2010) Multiple sclerosis genetics- is the glass half full, or half empty? Nat Rev Neurol 6:429-437.","DOI":"10.1038\/nrneurol.2010.91"},{"key":"key-10.4103\/1673-5374.266905-65","doi-asserted-by":"crossref","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13:25-36.","DOI":"10.1038\/nrneurol.2016.187"},{"key":"key-10.4103\/1673-5374.266905-66","doi-asserted-by":"crossref","unstructured":"Paul A, Comabella M, Gandhi R (2019) Biomarkers in multiple sclerosis. Cold Spring Harb Perspect Med doi: 10.1101\/cshperspect.a029058.","DOI":"10.1101\/cshperspect.a029058"},{"key":"key-10.4103\/1673-5374.266905-67","unstructured":"Pender MP, Burrows SR (2014) Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunology 3:e27."},{"key":"key-10.4103\/1673-5374.266905-68","doi-asserted-by":"crossref","unstructured":"Peplow PV, Martinez B, Calin GA, Esquela-Kerscher A (2019) MicroRNAs in Diseases and Disorders: Emerging Therapeutic Targets. London, UK: Royal Society of Chemistry Publishing.","DOI":"10.1039\/9781788016421"},{"key":"key-10.4103\/1673-5374.266905-69","doi-asserted-by":"crossref","unstructured":"Peterson MF, Otoc N, Sethi JK, Gupta A, Antes TJ (2015) Integrated systems for exosome investigation. Methods 87:31-45.","DOI":"10.1016\/j.ymeth.2015.04.015"},{"key":"key-10.4103\/1673-5374.266905-70","doi-asserted-by":"crossref","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292-302.","DOI":"10.1002\/ana.22366"},{"key":"key-10.4103\/1673-5374.266905-71","doi-asserted-by":"crossref","unstructured":"Pua HH, Steiner DF, Patel S, Gonzalez JR, Ortiz-Carpena JF, Kageyama R, Chiou NT, Gallman A, de Kouchkovsky D, Jeker LT, McManus MT, Erle DJ, Ansel KM (2016) MicroRNAs 24 and 27 suppress allergic inflammation and target a network of regulators of T helper 2 cell-associated cytokine production. Immunity 44:821-832.","DOI":"10.1016\/j.immuni.2016.01.003"},{"key":"key-10.4103\/1673-5374.266905-72","doi-asserted-by":"crossref","unstructured":"Pusic AD, Pusic KM, Kraig RP (2014) What are exosomes and how can they be used in multiple sclerosis therapy? Expert Rev Neurother 14:353-355.","DOI":"10.1586\/14737175.2014.890893"},{"key":"key-10.4103\/1673-5374.266905-73","doi-asserted-by":"crossref","unstructured":"Quintana E, Ortega FJ, Robles-Cede\u00f1o R, Villar ML, Bux\u00f3 M, Mercader JM, Alvarez-Cerme\u00f1o JC, Pueyo N, Perkal H, Fern\u00e1ndez-Real JM, Rami\u00f3-Torrent\u00e0 L (2017) miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands. Mult Scler 23:1716-1726.","DOI":"10.1177\/1352458516684213"},{"key":"key-10.4103\/1673-5374.266905-74","doi-asserted-by":"crossref","unstructured":"Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, Weiner HL, Gandhi R, Bakshi R (2017) Association between serum microRNAs and magnetic resonance imaging measures of multiple sclerosis severity. JAMA Neurol 74:275-285.","DOI":"10.1001\/jamaneurol.2016.5197"},{"key":"key-10.4103\/1673-5374.266905-75","doi-asserted-by":"crossref","unstructured":"Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola A, Raheja R, Glanz BI, Kivisakk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R (2018) Identification of MS-specific serum miRNAs in an international multicenter study. Neurol Neuroimmunol Neuroinflamm 5:e491.","DOI":"10.1212\/NXI.0000000000000491"},{"key":"key-10.4103\/1673-5374.266905-76","doi-asserted-by":"crossref","unstructured":"Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T, Mazzola MA, Raheja R, Nejad P, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Gandhi R (2016) Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e267.","DOI":"10.1212\/NXI.0000000000000267"},{"key":"key-10.4103\/1673-5374.266905-77","unstructured":"Reiber H (1998) Cerebrospinal fluid \u2013 physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 4:99-107."},{"key":"key-10.4103\/1673-5374.266905-78","doi-asserted-by":"crossref","unstructured":"Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, Moreau T, Lubetzki C, Vermersch P, Roullet E, Magy L, Tardieu M, Suissa S, Confavreux C (2007) Natural history of multiple sclerosis with childhood onset. N Eng J Med 356:2603-2613.","DOI":"10.1056\/NEJMoa067597"},{"key":"key-10.4103\/1673-5374.266905-79","unstructured":"Rodgers JM, Robinson AP, Miller SD (2013) Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discov Med16:53-63."},{"key":"key-10.4103\/1673-5374.266905-80","doi-asserted-by":"crossref","unstructured":"Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, et al. (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64:1144-1151.","DOI":"10.1212\/01.WNL.0000156155.19270.F8"},{"key":"key-10.4103\/1673-5374.266905-81","doi-asserted-by":"crossref","unstructured":"Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW, Mycko MP (2017) Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol 81:703-717.","DOI":"10.1002\/ana.24931"},{"key":"key-10.4103\/1673-5374.266905-82","doi-asserted-by":"crossref","unstructured":"Sharaf-Eldin WE, Kishk NA, Gad YZ, Hassan H, Ali MAM, Zaki MS, Mohamed MR, Essawi ML (2017) Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases. J Neurol Sci 383:188-198.","DOI":"10.1016\/j.jns.2017.11.014"},{"key":"key-10.4103\/1673-5374.266905-83","unstructured":"Sheinerman KS, Umansky SR (2013) Circulating cell-free microRNA as biomarkers for screening, diagnosis, and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7:150."},{"key":"key-10.4103\/1673-5374.266905-84","doi-asserted-by":"crossref","unstructured":"Shin D, Shin JY, McManus MT, Pt\u00e1cek LJ, Fu YH (2009) Dicer ablation in oligodendrocytes provokes neural impairment in mice. Ann Neurol 66:843-857.","DOI":"10.1002\/ana.21927"},{"key":"key-10.4103\/1673-5374.266905-85","doi-asserted-by":"crossref","unstructured":"Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH, Rehimi H (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12:1160-1165.","DOI":"10.1016\/j.autrev.2013.07.003"},{"key":"key-10.4103\/1673-5374.266905-86","doi-asserted-by":"crossref","unstructured":"S\u00f8ndergaard HB, Hesse D, Krakauer M, S\u00f8rensen PS, Sellebjerg F (2013) Differential microRNA expression in blood in multiple sclerosis. Mult Scler 19:1849-1857.","DOI":"10.1177\/1352458513490542"},{"key":"key-10.4103\/1673-5374.266905-87","doi-asserted-by":"crossref","unstructured":"Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172:146-155.","DOI":"10.2353\/ajpath.2008.070690"},{"key":"key-10.4103\/1673-5374.266905-88","doi-asserted-by":"crossref","unstructured":"Vistbakka J, Elovaara I, Lehtim\u00e4ki T, Hagman S (2017) Circulating microRNAs as biomarkers in progressive multiple sclerosis. Mult Scler 23:403-412.","DOI":"10.1177\/1352458516651141"},{"key":"key-10.4103\/1673-5374.266905-89","doi-asserted-by":"crossref","unstructured":"Vistbakka J, Sumelahti ML, Lehtim\u00e4ki T, Elovaara I, Hagman S (2018) Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients. Acta Neurol Scand 138:130-136.","DOI":"10.1111\/ane.12921"},{"key":"key-10.4103\/1673-5374.266905-90","doi-asserted-by":"crossref","unstructured":"Wang YF, He DD, Liang HW, Yang D, Yue H, Zhang XM, Wang R, Li B, Yang HX, Liu Y, Chen Y, Duan YX, Zhang CY, Chen X, Fu J (2017) The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis. Clin Exp Immunol 189:120-126.","DOI":"10.1111\/cei.12954"},{"key":"key-10.4103\/1673-5374.266905-91","doi-asserted-by":"crossref","unstructured":"Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, Hoang T, Xu X, Mi QS, Xin M, Wang F, Appel B, Lu QR (2010) MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65:612-626.","DOI":"10.1016\/j.neuron.2010.02.018"},{"key":"key-10.4103\/1673-5374.266905-92","doi-asserted-by":"crossref","unstructured":"Zhou J, Zhang J (2014) Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction. Mol Med Rep 10:971-976.","DOI":"10.3892\/mmr.2014.2245"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:34:31Z","timestamp":1786732471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.266905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["266905"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.266905","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}